XML 41 R27.htm IDEA: XBRL DOCUMENT
v3.25.4

Note 17 - Income Taxes | 12 Months Ended
--- | ---
Dec. 31, 2025
Notes to Financial Statements |
Income Tax Disclosure [Text Block] | 17. Income Taxes Income Tax Expense The components of the Company’s income (loss) before income taxes and its provision for (benefit from) income taxes consist of the following:
|  | Years ended December 31, |
|  | 2025 |  |  | 2024 |  |  | 2023 |
(Loss) income before income taxes |  |  |  |  |  |  |  |  |  |  |  |
Domestic |  | $ | (10,247 | ) |  | $ | (4,078 | ) |  | $ | 2,421 |
Foreign |  |  | 940 |  |  |  | 1,314 |  |  |  | 735 |
|  | $ | (9,307 | ) |  | $ | (2,764 | ) |  | $ | 3,156 |
|  | Years ended December 31, |
|  | 2025 |  |  | 2024 |  |  | 2023 |
Provision for income taxes: |  |  |  |  |  |  |  |  |  |  |  |
Current: |  |  |  |  |  |  |  |  |  |  |  |
Federal |  | $ | 176 |  |  | $ | 4,044 |  |  | $ | 4,910 |
State |  |  | 185 |  |  |  | 1,370 |  |  |  | 457 |
Foreign |  |  | 250 |  |  |  | 421 |  |  |  | 312 |
Total current |  |  | 611 |  |  |  | 5,835 |  |  |  | 5,679 |
Deferred: |  |  |  |  |  |  |  |  |  |  |  |
Federal |  |  | - |  |  |  | - |  |  |  | 1,579 |
State |  |  | - |  |  |  | - |  |  |  | (692 | )
Foreign |  |  | 61 |  |  |  | 229 |  |  |  | 29 |
Total deferred |  |  | 61 |  |  |  | 229 |  |  |  | 916 |
Total provision for income taxes |  | $ | 672 |  |  | $ | 6,064 |  |  | $ | 6,595 |
Deferred Tax Assets and Liabilities Significant components of the Company’s deferred tax assets and liabilities consist of the following:
|  | December 31, |
|  | 2025 |  |  | 2024 |
Deferred tax assets: |  |  |  |  |  |  |  |
Capital loss carryforward |  | $ | 19,991 |  |  | $ | 20,714 |
Net operating loss carryforwards |  |  | 13,294 |  |  |  | 650 |
Capitalized research expenditures |  |  | 10,760 |  |  |  | 12,241 |
Lease liability |  |  | 6,400 |  |  |  | 6,555 |
Stock-based compensation expense |  |  | 3,629 |  |  |  | 3,908 |
Inventory reserves |  |  | 1,558 |  |  |  | 2,316 |
Compensation accrual |  |  | 1,182 |  |  |  | 1,202 |
Accrued expenses and other |  |  | 819 |  |  |  | 1,403 |
Acquisition-related intangible asset |  |  | 776 |  |  |  | 5,959 |
Tax credits |  |  | 612 |  |  |  | - |
Impairment of assets |  |  | - |  |  |  | 4,215 |
Foreign currency exchange |  |  | - |  |  |  | 48 |
Gross deferred tax assets |  |  | 59,021 |  |  |  | 59,211 |
Less: Valuation allowance |  |  | (45,581 | ) |  |  | (45,148 | )
Deferred tax assets |  | $ | 13,440 |  |  | $ | 14,063 |
|  | December 31, |
|  | 2025 |  |  | 2024 |
Deferred tax liabilities: |  |  |  |  |  |  |  |
Depreciation |  | $ | (6,033 | ) |  | $ | (6,552 | )
Right of use asset |  |  | (6,132 | ) |  |  | (6,292 | )
Acquisition-related intangible asset |  |  | - |  |  |  | (42 | )
Deferred tax liabilities |  | $ | (12,165 | ) |  | $ | (12,886 | )
Net deferred tax assets |  | $ | 1,275 |  |  | $ | 1,177 |
The One Big Beautiful Bill Act (the “OBBBA”), was enacted on July 4, 2025, among other things, repealed the mandatory capitalization of Internal Revenue Code Section 174 research and development expenditures allowing taxpayers to fully expense qualifying costs in the year incurred. The Company does not expect to accelerate the write-off of previously capitalized research and development costs. This approach results in a more consistent pattern of deductions and moderates the creation of additional tax attributes. The OBBBA did not otherwise have a material impact on the Company’s consolidated financial statements. As of December 31, 2025, the Company had $53.7 million and $34.5 million of Federal and State net operating loss (“NOL”) carryforwards, of which $53.7 million and $11.6million, respectively, do not expire and $22.9 million of State net operating losses that will begin expiring in 2036. The Company also had NOL carryforwards in Italy of $1.6 million that do not expire. As of December 31, 2025, the Company had $0.4 million of Federal research and development credits and $0.2 million of State credits that begin expiring in 2028. The Company recognizes deferred tax assets to the extent that it believes that these assets are more likely than not to be realized. In making such a determination, the Company considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax-planning strategies, carryback potential if permitted under the tax law, and results of recent operations. Based upon future reversals of existing taxable temporary differences and projected future taxable income, the Company believes it is more likely than not it will realize its foreign deferred tax assets. The Company recorded a full valuation allowance on all deferred tax assets in the U.S. as it was determined that it is more likely than not that these deferred tax assets were not realizable as of December 31, 2025 and 2024. The Company intends to maintain a full valuation allowance until there is sufficient evidence to support release of all or a portion of the allowance. As of December 31, 2025, the Company continues to believe its foreign deferred tax assets are realizable based upon future reversals of existing taxable temporary differences and projected future taxable income in the Company’s foreign jurisdictions. Undistributed earnings of certain of the Company’s foreign subsidiaries amounted to approximately $0.7 million at December 31, 2025. The Company expects to be able to take a 100% dividend received deduction to offset any U.S. federal income tax liability on the undistributed earnings. Determination of the amount of unrecognized state and local deferred income tax liability is not practicable due to the complexities associated with its hypothetical calculation. Effective Tax Rate During the year ended December 31, 2025, the Company adopted Accounting Standards Update 2023-09, Improvements to Income Tax Disclosures, (“ASU 2023-09”). ASU 2023-09 requires additional disclosures for income tax reporting, primarily related to a requirement for companies to disaggregate their income tax rate reconciliation. The Company adopted ASU 2023-09 on a prospective basis and a tabular income tax rate reconciliation pursuant to the disclosure requirements of ASU 2023-09 for the year ended December 31, 2025 is as follows:
|  | Year ended December 31, 2025 |
|  | Amount |  |  | Percent |
Statutory federal income tax rate |  | $ | (1,954 | ) |  |  | 21.0 | %
State tax expense, net of federal provision** |  |  | 207 |  |  |  | (2.2 | %)
Foreign tax effects: |  |  |  |  |  |  |  |
Italy |  |  | 196 |  |  |  | (2.1 | %)
Other foreign jurisdictions |  |  | 63 |  |  |  | (0.7 | %)
Effect of cross-border tax laws: |  |  |  |  |  |  |  |
Global intangible low-taxed income, net |  |  | 371 |  |  |  | (4.0 | %)
Tax credits: |  |  |  |  |  |  |  |
Research and development tax credits |  |  | (416 | ) |  |  | 4.5 | %
Change in valuation allowance |  |  | (13 | ) |  |  | 0.1 | %
Nontaxable or nondeductible items: |  |  |  |  |  |  |  |
Stock-based compensation |  |  | 1,092 |  |  |  | (11.7 | %)
Section 162(m) limitation |  |  | 616 |  |  |  | (6.5 | %)
Other |  |  | 43 |  |  |  | (0.5 | %)
Other reconciling items: |  |  |  |  |  |  |  |
Return to provision adjustments |  |  | 591 |  |  |  | (6.4 | %)
Other |  |  | (124 | ) |  |  | 1.4 | %
Effective income tax rate |  | $ | 672 |  |  |  | (7.1 | %)
**State taxes in Indiana, Massachusetts and Kentucky made up the majority (greater than 50 percent) of the tax effect in this category. The reconciliation between the U.S. federal statutory rate and the Company’s effective rate for the years ended December 31, 2024 and 2023 is summarized as follows:
|  | Years ended December 31, |
|  | 2024 |  |  | 2023 |
Statutory federal income tax rate |  |  | 21.0 | % |  |  | 21.0 | %
State tax expense, net of federal benefit |  |  | (52.2 | %) |  |  | 9.5 | %
Stock-based compensation |  |  | (17.2 | %) |  |  | 11.8 | %
Section 162(m) limitation |  |  | (30.1 | %) |  |  | 28.3 | %
Change in tax rates and state apportionment |  |  | 10.4 | % |  |  | - | %
Federal, state and foreign tax credits |  |  | 22.5 | % |  |  | (23.1 | %)
Change in valuation allowance |  |  | (157.3 | %) |  |  | 173.0 | %
Return to provision adjustments |  |  | 5.5 | % |  |  | (3.6 | %)
Tax reserves |  |  | (20.9 | %) |  |  | - | %
Other permanent items |  |  | (1.1 | %) |  |  | (7.9 | %)
Effective income tax rate |  |  | (219.4 | %) |  |  | 209.0 | %
Income Tax Payments A summary of income taxes paid, net of refunds, by jurisdiction pursuant to the disclosure requirements of ASU 2023-09 for the year ended December 31, 2025 is as follows:
|  | Year ended December 31, |
|  | 2025 |
United States - Federal |  | $ | 250 |
United States – State and local |  |  | 69 |
Canada |  |  | 76 |
Italy |  |  | 481 |
United Kingdom |  |  | 154 |
Other |  |  | 46 |
|  | $ | 1,076 |
Accounting for Uncertainty in Income Taxes The Company has $0.3 million and $0.6 million of unrecognized tax benefits for the years ended December 31, 2025 and 2024, respectively. The Company files income tax returns in the United States on a federal basis, in certain U.S. states, and in certain foreign jurisdictions. The associated tax filings remain subject to examination by applicable tax authorities for a certain length of time following the tax year to which those filings relate. With a few exceptions, the Company is no longer subject to income tax examinations for years prior to 2021. In September 2024, the Company was notified by the Italian tax authorities that it had selected the Company’s tax returns for its Italian subsidiary for 2021 for examination. The examination was completed in the quarter ended December 31, 2025 and the Company paid $0.4 million in income taxes which reduced the unrecognized tax benefit by $0.2 million during the year ended December 31, 2025.

X
- References No definition available. + Details
Name: | us-gaap_DisclosureTextBlockAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for income tax. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 942 -SubTopic 740 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477617/942-740-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 740 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478822/944-740-50-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 12 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12 Reference 5: http://www.xbrl.org/2003/role/exampleRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 231 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 12C -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12C Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 12B -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12B Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 270 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147477891/740-270-50-1 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 6.I.5.Q1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480990/946-20-50-13 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(h)(2)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/740/tableOfContent Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-14 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 21 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-21 Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 17 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17 Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SAB Topic 11.C) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-2 Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482603/740-30-50-2 + Details
Name: | us-gaap_IncomeTaxDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration